Company / Working Capital
Zoetis Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$4.5B
FY2025
5-year range
$2.6B / $5.1B
FY2021-FY2025
Trend
+76.1%
vs FY2024
Sector context
#10 of 213
Health Care
What the data says
Among 213 Health Care companies, Zoetis is in the top 5% for working capital. Working Capital has fluctuated over the past 10 years, ranging from $2.3B in FY2016 to $5.1B in FY2021.
Based on SEC 10-K filings.
$4.5B in FY2025 with a 5-year CAGR of +0.4%. Top quartile in the Health Care sector.
Remained stable around $4.5B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +1.5%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 213This company $4.5B Sector average $934.6M
▼
+385.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.4%, indicating consistent growth.
- In FY2025, working capital increased 76.1% year-over-year.
- Ranks #10 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Strong profit margin: 28.2%
- Strong return on equity: 49.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.5B | +76.1% |
| FY2024 | $2.6B | -42.2% |
| FY2023 | $4.5B | +2.7% |
| FY2022 | $4.3B | -15.5% |
| FY2021 | $5.1B | +15.6% |
| FY2020 | $4.4B | +51.0% |
| FY2019 | $2.9B | -7.4% |
| FY2018 | $3.2B | +1.7% |
| FY2017 | $3.1B | +37.4% |
| FY2016 | $2.3B | +10.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026